Twist Bioscience Corp reports results for the quarter ended in March - Earnings Summary

Twist Bioscience

03/05/2024 23:26

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of 79 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-1.04.  The mean expectation of nine analysts
for the quarter was for a loss of 82 cents per share. Wall
Street expected results to range from -86 cents to -76 cents per
share.
    * Revenue rose 25.1% to $75.30 million from a year ago;
analysts
expected $70.66 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of 79 cents​.
    * The company reported a quarterly loss of $45.49 million.
    * Twist Bioscience Corp shares had fallen by 6.7% this
quarter and
lost 13.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Twist Bioscience
Corp is $44.00 
This summary was machine generated from LSEG data May 3 at 10:26
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.82          -0.79          Beat
 Dec. 31 2023      -0.78          -0.75          Beat
 Sep. 30 2023      -0.92          -0.81          Beat
 Jun. 30 2023      -1.14          -0.78          Beat